140 related articles for article (PubMed ID: 36228936)
1. Prognostic factors for the development of acneiform eruptions in patients on epidermal growth factor receptor inhibitors.
Bierbrier R; D'Aguanno K; Kasymjanova G; Dell'Aniello S; Agulnik J; Pehr K
J Am Acad Dermatol; 2023 Apr; 88(4):869-870. PubMed ID: 36228936
[No Abstract] [Full Text] [Related]
2. Efficacy of topical epidermal growth factor cream for patients with epidermal growth factor receptor inhibitor-induced acneiform eruption: a randomized controlled trial.
Lee JH; Ju HJ; Kwon HS; Jung HM; Kim GM; Bae JM; An HJ
Br J Dermatol; 2020 Jan; 182(1):219-221. PubMed ID: 31301244
[No Abstract] [Full Text] [Related]
3. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients.
Katzer K; Tietze J; Klein E; Heinemann V; Ruzicka T; Wollenberg A
Eur J Dermatol; 2010; 20(1):82-4. PubMed ID: 19797039
[TBL] [Abstract][Full Text] [Related]
4. Images in clinical medicine. Cetuximab-associated acneiform eruption.
Moss JE; Burtness B
N Engl J Med; 2005 Nov; 353(19):e17. PubMed ID: 16282170
[No Abstract] [Full Text] [Related]
5. [Contribution to acneiform eruptions by epidermal growth factor receptor inhibitors].
Bodet D; Bartralot R; Mollet J; Heras C; García-Patos V
Actas Dermosifiliogr; 2006 Mar; 97(2):148-9. PubMed ID: 16595122
[No Abstract] [Full Text] [Related]
6. Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.
Requena C; Llombart B; Sanmartín O
Cutis; 2012 Aug; 90(2):77-80. PubMed ID: 22988651
[TBL] [Abstract][Full Text] [Related]
7. Survey of Oncologists and Dermatologists in Canada on the Management of Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors.
Bierbrier R; Esfahani K; Pehr K
J Cutan Med Surg; 2022; 26(6):624-625. PubMed ID: 35980317
[No Abstract] [Full Text] [Related]
8. [Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid].
Wollenberg A; Moosmann N; Kroth J; Heinemann V; Klein E
Hautarzt; 2007 Jul; 58(7):615-8. PubMed ID: 17146641
[TBL] [Abstract][Full Text] [Related]
9. Reader Comment Regarding "Survey of Oncologists and Dermatologists in Canada on the Management of Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors".
Fournier C; Sauder MB
J Cutan Med Surg; 2023; 27(3):294. PubMed ID: 36927192
[No Abstract] [Full Text] [Related]
10. An Analysis of Risk Factors for the Development of Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.
Bierbrier R; D'Aguanno K; Oliel S; Zeng Y; Esfahani K; Pehr K
J Cutan Med Surg; 2023 Nov; 27(6):614-620. PubMed ID: 37942582
[TBL] [Abstract][Full Text] [Related]
11. Cetuximab-induced acneiform eruption and the response to isotretinoin.
Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
[No Abstract] [Full Text] [Related]
12. Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta-analysis.
Gorji M; Joseph J; Pavlakis N; Smith SD
Asia Pac J Clin Oncol; 2022 Dec; 18(6):526-539. PubMed ID: 35352492
[TBL] [Abstract][Full Text] [Related]
13. [Acneiform eruption from epidermal growth factor receptor inhibitors].
Martínez de Lagrán Z; Ratón JA; Lasa O; Acebo E; Díaz-Pérez JL
Actas Dermosifiliogr; 2005 Sep; 96(7):450-4. PubMed ID: 16476273
[TBL] [Abstract][Full Text] [Related]
14. [Acneiform eruptions induced by cetuximab].
Walon L; Gilbeau C; Lachapelle JM
Ann Dermatol Venereol; 2003 Apr; 130(4):443-6. PubMed ID: 12843857
[TBL] [Abstract][Full Text] [Related]
15. Differences in Management Between Dermatologists and Oncologists for Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.
Oliel S; Bierbrier R; D'Aguanno K; Esfahani K; Pehr K
J Cutan Med Surg; 2024; 28(1):79-81. PubMed ID: 38156654
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induced by cetuximab and panitumumab: A multicenter, phase II trial.
Tsutsui K; Kikuchi K; Nozawa K; Takashima A; Tsuchiyama K; Namikawa K; Aiba S; Yamazaki N
J Dermatol; 2021 Jul; 48(7):1077-1080. PubMed ID: 33682955
[TBL] [Abstract][Full Text] [Related]
17. Rosaceiform eruption induced by cetuximab.
Fernández-Torres R; Martínez Gomez W; Cuevas Santos J; Paradela S; Fonseca Capdevila E
Eur J Dermatol; 2010; 20(3):392-3. PubMed ID: 20172848
[No Abstract] [Full Text] [Related]
18. Severe acneiform eruption induced by cetuximab (Erbitux).
Lee JE; Lee SJ; Lee HJ; Lee JH; Lee KH
Yonsei Med J; 2008 Oct; 49(5):851-2. PubMed ID: 18972607
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with adapalene of cetuximab-induced acneiform eruptions.
Taguchi K; Fukunaga A; Okuno T; Nishigori C
J Dermatol; 2012 Sep; 39(9):792-4. PubMed ID: 22168666
[No Abstract] [Full Text] [Related]
20. [Epidermal growth factor receptor inhibitors side effects].
Guhl G; González-de Arriba A; Daudén E
Actas Dermosifiliogr; 2006 Jun; 97(5):296-310. PubMed ID: 16956561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]